'We Have The Means To Prevent 80% Heart Attacks And Strokes', Expert Urges NHS To Give 'Polypill'

Updated Mar 6, 2025 | 05:00 AM IST

SummaryA polypill combining statins and blood pressure drugs could prevent 80% of heart attacks and strokes. Research shows it cuts cardiovascular risk by a third, benefiting millions globally with minimal side effects.
'We Have The Means To Prevent 80% Heart Attacks And Strokes', Expert Urges NHS To Give 'Polypill'

Image Credits: Canva

Heart attacks and strokes are among the leading causes of death globally, with millions suffering from cardiovascular diseases (CVD) every year. There are more than seven million people in the UK alone, with about 100,000 patients experiencing heart attacks annually. However, a group of researchers at University College London (UCL) estimate that one 'polypill' taken daily day could eliminate a majority of these cases dramatically lowering death tolls.

The proposed polypill, a combination of a statin and three blood pressure-lowering drugs, has been under study for over two decades. Experts argue that introducing this pill universally for individuals aged 50 and above could be more effective than the current NHS Health Check, which assesses risk factors every five years for those aged between 40 and 74.

Studies have repeatedly proven the effectiveness of the polypill in preventing CVD. A groundbreaking 2019 study in The Lancet found that five years' use of the polypill cut the risk of heart attack and stroke by a third. In addition, previous modelling analyses have estimated that if given universally to people over 55, the polypill might be able to prevent 80% of heart attacks and strokes.

Today, the NHS Health Check follows a risk-based model in which patients are tested for CVD risk factors and treated with drugs accordingly. Yet, as per UCL's study, this system has serious flaws:

Low Uptake: Just 40% of those eligible for the NHS Health Check choose to have it, leaving a considerable number of at-risk patients undiagnosed and untreated.

Ineffective Prediction of Risk: The majority of heart attacks and strokes happen to people at average risk levels, thus making it challenging to identify the need for intervention effectively.

Limited Effectiveness: Even at maximum take-up, the NHS Health Check programme is predicted to have fewer health impacts compared to a polypill initiative applied to the whole population.

Simplicity and Affordability of the Polypill Strategy

One of the big benefits of the polypill is that it is so easy. In contrast to the existing screening-based model, the polypill scheme would not involve complicated medical tests or lengthy risk assessments. Instead, people reaching 50 would just have to fill out a few questions to determine possible side effects before they were prescribed.

Professor Aroon Hingorani of the UCL Institute of Cardiovascular Science, one of the strongest proponents of this scheme, says:

"Finally, the time is now to do much better on prevention. A population approach would prevent a lot more heart attacks and strokes than is done today with a strategy of trying to target a smaller group only."

Aside from the possible health implications, the polypill is also an economic solution. The drugs used are off-patent, thus cheap to produce and distribute. With the vast economic cost of managing CVD-related illnesses, a preventive model could result in substantial cost-saving for the NHS in the future.

The polypill has been proven to be effective by numerous international trials. In 2019, a randomised trial in rural Iran discovered that participants who took the polypill for five years had a 34% reduced risk of having a heart attack or stroke compared to non-participants.

Likewise, modelling research has indicated that even if only 8% of people aged over 50 took up the polypill regimen, it would still be more beneficial to their health than the NHS Health Check programme.

Is This a Case of Over-Medicalisation?

One of the main objections to the polypill strategy is the suggestion that it might result in the unnecessary medicalisation of a significant proportion of the population. But, it is argued, it should be considered as a preventative measure, not as mass medication.

Professor Sir Nicholas Wald of UCL's Institute of Health Informatics explains:

"Instead of being a 'medicalisation' of a significant proportion of the population, a polypill programme is a prevention measure to prevent an individual from becoming a patient."

He compares it with public health measures like water fluoridation or compulsory seatbelts—interventions that have been shown to have a significant impact in reducing public health danger at low individual cost.

With the evidence in favour of the polypill's effectiveness and viability overwhelming, experts are calling on the NHS to act now. It is their belief that substituting the NHS Health Check with a polypill-based prevention program could be the UK government's flagship policy under its pledge to put disease prevention ahead of cure.

As Professor Hingorani points out, "The status quo is not a justifiable option." With CVD still a major cause of death globally, taking a population-wide polypill approach could be a turning point for preventative medicine, potentially saving thousands of lives annually. The question now is whether the NHS will take up this call and establish a policy with the potential to transform the prevention of cardiovascular disease on a national level.

End of Article

NASA Warns 2026 'Monster' El Niño Could Surpass 1997 Event: How It Could Affect Your Health

Updated Nov 16, 2026 | 07:00 PM IST

SummaryNASA scientists warn that the 2026–27 El Niño could rival or surpass the historic 1997–98 event. The potentially record-breaking climate phenomenon could intensify heatwaves, worsen air quality, alter infectious disease risks and increase food insecurity, raising concerns about its global public health impact.
NASA Warns 2026 'Monster' El Niño Could Surpass 1997 Event: How It Could Affect Your Health

Credit: iStock

NASA scientists warn that the developing 2026–27 El Niño could rival or surpass the powerful 1997–98 event, which triggered severe droughts, fires and flooding worldwide.

The new findings amid climate deliberations taking place at the COP31 in Turkiye.

Using 35 years of satellite observations, researchers are comparing the current event with previous strong El Niños. The climate phenomenon, marked by warmer-than-average sea-surface temperatures in the central and eastern equatorial Pacific, can disrupt weather patterns worldwide and raise global temperatures.

The 1997–98 and 2015–16 events were among the strongest on record, bringing fires to Indonesia and the Amazon, droughts in southern Africa, and heavy rainfall in Southern California.

How Does The 2026 El Niño Compare With The 1997 Event?

Also read: El Niño Could Worsen Dengue, Malaria And Heat Illness: Why WHO Declared A Health Emergency

Satellite altimetry measures changes in ocean surface height, helping scientists track heat accumulation in the Pacific. Warmer seawater expands, raising sea levels.

"What's unique about altimetry is that we have a 35-year record from nearly identical satellites flying almost the same ground track, with each mission overlapping the next," said Josh Willis, project scientist for sea level missions at NASA's Jet Propulsion Laboratory (JPL). "That lets us look back in time and compare this El Niño to what happened in 1997. And right now, this one is on track to be even bigger."

NASA's October measurements show similarities between the two events, including lower sea levels in the western Pacific, higher levels in the east and unusually warm water extending towards South America.

These patterns raise the possibility of similar weather effects, including substantial rainfall across California and the southern United States this winter.

Could The 2026–27 El Niño Become One Of The Strongest On Record?

Read More: Climate Crisis Is A Health Crisis: Just 6 Actions Could Save 1.6 Million Lives, Says WHO

NOAA's October 8 outlook estimated an 83% chance of strong to very strong El Niño conditions during the first three months of 2027.

On November 12, its Climate Prediction Center classified the event as "very strong", the highest of four intensity categories. Only three other events since 1950 have reached this level: 1982–83, 1997–98 and 2015–16.

However, El Niño's effects vary by region and do not guarantee the same weather extremes everywhere.

How Could The Super El Niño Affect Your Health?

The World Meteorological Organization (WMO) warns that El Niño could amplify climate change-related health risks, including:

  • Extreme heat: More intense heatwaves could increase heat-related illnesses and deaths.
  • Poor air quality: Wildfires could expose more people to smoke and pollution.
  • Infectious diseases: Changing weather patterns could alter the risk of dengue, malaria and cholera.
  • Food insecurity: Disrupted agriculture could worsen malnutrition and water shortages.
  • Extreme weather: Floods and storms could increase injuries, deaths and pressure on healthcare systems.

El Niño Could Push 49 Million More People Into Acute Hunger

A World Food Programme (WFP) analysis published in October projected that El Niño could push 49 million additional people into acute food insecurity by the end of 2027, taking the global total from 225 million to 274 million.

At least 45 countries could experience worsening food insecurity, particularly communities dependent on rain-fed agriculture. WFP warns that the effects could persist through 2027 and into early 2028.

End of Article

Lung Cancer In Non-Smokers: AIIMS Oncologist Says Cases Are Rising Among Young People And Women, Explains PM2.5 Link

Updated Nov 16, 2026 | 03:47 PM IST

SummaryDr Abhishek Shankar from AIIMS, says lung cancer is increasingly affecting non-smokers, particularly younger people and women. He identifies PM2.5 pollution as an emerging risk factor, with research underway to understand the link and identify vulnerable groups.
Lung Cancer In Non-Smokers: AIIMS Oncologist Says Cases Are Rising Among Young People And Women, Explains PM2.5 Link

Credit: iStock

Air pollution is emerging as an important risk factor for lung cancer in India, with more young people and women who have never smoked being diagnosed with the disease, said Dr Abhishek Shankar, Associate Professor of Radiation Oncology at the All India Institute of Medical Sciences (AIIMS).

Speaking to HealthandMe, Dr Abhishek said nearly 50% of lung cancer cases are now unrelated to smoking, marking a shift from the earlier pattern, when more than 90% of cases were associated with smoking.

“So, now we see that nearly 50% lung cancer cases are not related to smoking, otherwise it was more than 90% related to smoking,” he said.

More Never Smokers Are Being Diagnosed

Also read: 91% Of Indian Studies Spanning 50 Years Link Air Pollution To Diabetes, Heart Disease And Cancer

Lung cancer has traditionally been associated with older male smokers. However, Dr Abhishek said he is seeing more younger people and women who have never smoked being diagnosed with the disease.

He believes air pollution could be contributing to this changing pattern.

“Now the air pollution is emerging as a risk factor and when we have more number of younger people and women who never smoke, never been exposed to any kind of, you know, second or third smoke is now coming with lung cancer.”

How Is PM2.5 Linked To Lung Cancer?

“The answer is very simple that air pollution has a lot much to do in terms of lung cancer in India,” Dr Abhishek said.

According to the World Health Organization (WHO), 99% of the global population breathes air that exceeds its guideline limits and contains high levels of pollutants. Low- and middle-income countries face the highest exposures.

The International Agency for Research on Cancer (IARC) classified outdoor air pollution as a Group 1 carcinogen in 2013, identifying lung cancer as one of the cancers associated with exposure.

Delhi's air quality has deteriorated sharply in recent weeks following Diwali. PM2.5 concentrations in several parts of the capital exceeded 66 times the WHO's recommended 24-hour guideline.

Long-term exposure to fine particulate matter is also a concern for children, as it can impair lung development and affect the maximum lung capacity they attain in adulthood. PM2.5's tiny particles can penetrate deep into the lungs.

Dr Abhishek pointed to research examining the relationship between particulate matter and cancer.

“Now, there are studies about the causal relationship between air pollution and lung cancer, particularly PM 2.5.”

He added that researchers have also investigated the association between different air pollutants and cancer.

“So, there are many cancers which have been studied in reference to different components of AQI, primarily the PM 2.5, PM 10 and I think they have been associated with cancer.”

Researchers are also investigating whether specific biomarkers can help identify people more susceptible to pollution-related lung cancer.

“At the same time, we are just talking about the PM 2.5 exposure-based biomarkers; what are the, you know, unique biomarkers that are expressed only in PM 2.5 exposure-based lung cancer, and we want to identify the susceptible lung cancer population women in those cohorts.”

How Can People Reduce Exposure To Air Pollution?

Read More: Is India's Toxic Air Adding To Its Diabetes Crisis? What Experts Say

Dr Abhishek advised people to avoid going outdoors unless necessary during periods of severe pollution. However, he acknowledged that staying indoors is not always practical, particularly for those who need to commute to work.

He recommended wearing N95 masks to reduce exposure to fine particulate matter.

“N95 is useful. This is said to reduce exposure to the, you know, fine particles even.”

He also highlighted the use of indoor air purifiers, which can improve indoor air quality and make breathing easier. However, he noted that more research is needed to establish whether these measures reduce the risk of acute and chronic diseases.

AIIMS Studies To Examine Lung Cancer Risk And Screening

Dr Abhishek is involved in two studies examining air pollution, lung cancer risk and screening in India.

The AIR CARE study will investigate how different components of PM2.5 contribute to lung cancer, how pollution interacts with other risk factors such as smoking, and whether exposure-based risk assessment and biomarkers can help identify high-risk groups.

The second, the Indian Lung Screening Trial, will involve around 10 centres across the country. It will assess lung cancer screening among people aged 50–80 with a smoking history of at least 20 pack-years.

The trial aims to generate evidence on lung cancer screening in the Indian population, building on findings from international studies. Dr Abhishek said initial trends from both studies are expected by the end of next year.

End of Article

Can A 'Sponge On A String' Test Help Detect Oesophageal Cancer Before Symptoms?

Updated Nov 16, 2026 | 04:30 PM IST

SummaryEngland's National Health Service (NHS) wants to include 'sponge in the gullet test' in standard use to identify people with Barrett's oesophagus and rule out oesophageal cancer risk.
Can A 'Sponge On A String' Test Help Detect Oesophageal Cancer Before Symptoms?

Credit: AI-generated image

A simple test done with a dissolvable capsule and a tiny sponge is being proposed to be included in standard use to identify people at risk of oesophageal cancer. This could reduce the need for invasive tests.

The technology, known as the ‘sponge on a string’ test, is being considered for widespread use across England's National Health Service (NHS) under new recommendations.

The UK's National Institute for Health and Care Excellence (NICE) has recommended two capsule sponge tests, Cytosponge and EndoSign, for NHS deployment. The tests can be performed in GP surgeries, pharmacies and community diagnostic centres without needing sedation.

The development marks a significant step as oesophageal cancer is often diagnosed at an advanced stage when treatment becomes challenging. More than 9,000 people are diagnosed with that cancer in the UK every year.

How Does The 'Sponge On A String' Test Work?

Also read: Microplastics May Promote The Growth Of One Of The Deadliest Cancers: Study

The test is done by having the patient swallow a small capsule attached to a thin string. Once it reaches the stomach, the capsule dissolves and releases a compressed sponge.

After approximately five to seven minutes, a healthcare professional gently pulls the sponge back through the mouth with the help of the string. As it travels upwards through the oesophagus, it gathers the cells from the lining of the food pipe. These samples are then sent to a laboratory for analysis.

The test takes around seven minutes and does not require sedation. Unlike an endoscopy, it does not involve passing a camera through the throat to examine the oesophagus directly.

The cells that are collected are examined for Barrett's oesophagus, a condition in which the cells along the lining of the food pipe undergoes changes related to prolonged exposure to stomach acid.

Between one and two adults per 100 is believed to have Barrett's oesophagus. Even though most won't go on to develop cancer, the demand of endoscopy to rule out cancer risk remains high.

How Is Barrett's Oesophagus Linked To Cancer?

Also read: Ivonescimab: Why Did US FDA Reject China's Promising Lung Cancer Drug?

Barrett's oesophagus is commonly linked to long-term gastro-oesophageal reflux in which stomach acid repeatedly flows back into the oesophagus.

Over time, this can damage the lining and cause alterations in the cells. In some people, these changes can progress to dysplasia, where cells become increasingly abnormal and eventually turn into oesophageal cancer.

The capsule sponge tests are intended to help identify people with Barrett's oesophagus who may need further investigation.

Who Is Eligible For The Test?

The proposed NHS recommendations are meant for people with chronic acid reflux or indigestion. Reflux is caused due to a weak sphincter at the bottom of the oesophagus, where it meets the stomach. It may keep allowing the stomach acids to flow the wrong way. Common symptoms of acid reflux include:

  • Burning sensation in the chest commonly called heartburn.
  • An unpleasant acidic taste in the mouth.
  • Repeated regurgitation of stomach contents.
  • Chronic indigestion.

Professor Jonathan Benger, chief executive of NICE, said, “Capsule sponge tests offer a quick and less invasive way to detect concerning changes associated with oesophageal cancer or Barrett's oesophagus, helping to identify people who should go on to have further tests and treatment.”

Professor Peter Johnson, national clinical director for cancer at NHS England, said, “Many people have acid reflux, and having an easier way to check for changes in the lining of the oesophagus can make a big difference for patients – reducing the need for more complicated endoscopy tests and helping the NHS free up resources to find cancers at an earlier stage.”

End of Article